Moderna ETFs to Shine Bright on Booster Update, New Study Data
Investors have dual reasons to be upbeat about the Moderna MRNA stock. To begin with, the FDA has finally given a nod to the COVID-19 vaccine booster shots of Pfizer PFE-BioNTech or Moderna for people with weak immune systems. The decision has come at a…
